Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis
- 302 Downloads
During the transitional phase of premature ovarian insufficiency (POI), sporadic resumption of ovulation is possible because of fluctuation of hormonal levels but the chance of spontaneous pregnancy is low, and the main perspective of childbearing in these women is egg donation or adoption. The purpose of the study was to verify whether treatment with estrogens in POI patients in transitional phase could reduce FSH levels and to evaluate if this pre-treatment could improve reproductive outcomes of in vitro fertilization (IVF).
Study patients (26) were administered with valerate estradiol 2 mg daily adding dihydrogesterone 10 mg daily during luteal phase for 3 months before IVF. Control group (26 patients) did not receive any pre-treatment. Ovarian stimulation was conducted in both groups with the same short GnRH-antagonist protocol. Clinical and laboratory data of patients were retrospectively analyzed.
In the study group, 4/26 POI patients became spontaneously pregnant during pre-treatment. In the remaining patients, the mean level of FSH after the pre-treatment was significantly reduced compared with baseline. Levels of circulating estradiol on the day of hCG administration were significantly higher in the study group. The total number of MII oocytes retrieved and fertilized oocytes was significantly higher in the study group, as well as the number of embryos transferred for pickup and clinical pregnancy rate.
Treatment with estrogens in infertile POI patients in transitional phase reduces circulating FSH levels, hence causing potential spontaneous conception. Moreover, in these patients, estrogen pre-treatment seems to improve IVF outcomes in a GnRH-antagonist short protocol compared to no pre-treatment.
KeywordsPremature ovarian insufficiency IVF POF Estrogens Infertility
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
- 8.Shestakova IG, Radzinsky VE, Khamoshina MB. Occult form of premature ovarian insufficiency. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2016;32(sup2):30–2.Google Scholar
- 10.Maclaran K, Panay N. Current concepts in premature ovarian insufficiency. Womens Health. 2015;11(2):169–82.Google Scholar
- 17.Determina n. 1073/2016 Agenzia Italiana Del Farmaco (AIFA), nota 745. Gazzetta Ufficiale Serie Generale n.201 del 29-08-2016.Google Scholar
- 20.Veeck LL. Morphological estimation of mature oocytes and their preparation for insemination. In: Jones Jr HW, Jones GS, Hodgen GD, Rosenwaks Z, editors. In vitro fertilization, Norfolk. Baltimore: Williams and Wilkins; 1986. p. 81–93.Google Scholar
- 24.Santoro N. Research on the mechanisms of premature ovarian failure. J Soc Gynecol Investig, vol. 8, no. 1 Suppl Proceedings, pp. S10–2, 2001.Google Scholar
- 30.Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G. Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril. Apr. 2007;87(4):858–61.CrossRefPubMedGoogle Scholar
- 34.Tartagni R, Damiani R, Di Naro R, Persiani R, Crescini R, Loverro R. Pregnancy in a woman with premature ovarian insufficiency undergoing intracytoplasmic sperm injection after pretreatment with estrogens followed by therapy with estrogens associated with ovarian stimulation with gonadotropins: remarks about oocyte and embryo quality. Menopause. 2011;18(8):932–4.CrossRefPubMedGoogle Scholar
- 41.Parry JP, Koch CA. Ovarian reserve testing, in Endotext, L. J. De Groot, G. Chrousos, K. Dungan, K. R. Feingold, A. Grossman, J. M. Hershman, C. Koch, M. Korbonits, R. McLachlan, M. New, J. Purnell, R. Rebar, F. Singer, and A. Vinik, Eds. South Dartmouth (MA): MDText.com, Inc., 2000.